576 reports of this reaction
5.3% of all CALCIUM CARBONATE, MAGNESIUM HYDROXIDE reports
#4 most reported adverse reaction
END STAGE RENAL DISEASE is the #4 most commonly reported adverse reaction for CALCIUM CARBONATE, MAGNESIUM HYDROXIDE, manufactured by THE PROCTER & GAMBLE MANUFACTURING COMPANY. There are 576 FDA adverse event reports linking CALCIUM CARBONATE, MAGNESIUM HYDROXIDE to END STAGE RENAL DISEASE. This represents approximately 5.3% of all 10,871 adverse event reports for this drug.
Patients taking CALCIUM CARBONATE, MAGNESIUM HYDROXIDE who experience end stage renal disease should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
END STAGE RENAL DISEASE is moderately reported among CALCIUM CARBONATE, MAGNESIUM HYDROXIDE users, representing a notable but not dominant share of adverse events.
In addition to end stage renal disease, the following adverse reactions have been reported for CALCIUM CARBONATE, MAGNESIUM HYDROXIDE:
The following drugs have also been linked to end stage renal disease in FDA adverse event reports:
END STAGE RENAL DISEASE has been reported as an adverse event in 576 FDA reports for CALCIUM CARBONATE, MAGNESIUM HYDROXIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.
END STAGE RENAL DISEASE accounts for approximately 5.3% of all adverse event reports for CALCIUM CARBONATE, MAGNESIUM HYDROXIDE, making it a notable side effect.
If you experience end stage renal disease while taking CALCIUM CARBONATE, MAGNESIUM HYDROXIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.